pd 142893 has been researched along with angiotensin ii in 4 studies
| Studies (pd 142893) | Trials (pd 142893) | Recent Studies (post-2010) (pd 142893) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
|---|---|---|---|---|---|
| 64 | 0 | 3 | 38,152 | 1,089 | 7,413 |
| Protein | Taxonomy | pd 142893 (IC50) | angiotensin ii (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, BV; Camilión de Hurtado, MC; Cingolani, HE; Ennis, IL | 1 |
| Alvarez, BV; Cingolani, HE; de Hurtado, MC; Ennis, IL | 1 |
| de Champlain, J; Lamontagne, D; Millette, E | 1 |
| Achard, JM; Faure, S; Javellaud, J; Oudart, N | 1 |
4 other study(ies) available for pd 142893 and angiotensin ii
| Article | Year |
|---|---|
Stretch-induced alkalinization of feline papillary muscle: an autocrine-paracrine system.
Topics: Alkalies; Alkaloids; Amiloride; Angiotensin II; Animals; Anti-Arrhythmia Agents; Autocrine Communication; Benzophenanthridines; Cats; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Heart; Hydrogen-Ion Concentration; Losartan; Muscle Contraction; Muscle Fibers, Skeletal; Oligopeptides; Papillary Muscles; Paracrine Communication; Peptides, Cyclic; Phenanthridines; Protein Kinase C; Sodium-Hydrogen Exchangers | 1998 |
Stimulation of myocardial Na(+)-independent Cl(-)-HCO(3)(-) exchanger by angiotensin II is mediated by endogenous endothelin.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; Alkalies; Angiotensin II; Animals; Antiporters; Bicarbonates; Buffers; Carbon Dioxide; Cats; Chloride-Bicarbonate Antiporters; Endothelin Receptor Antagonists; Endothelins; Hydrogen-Ion Concentration; Methylamines; Myocardium; Oligopeptides; Peptides, Cyclic; Rats; Receptor, Endothelin A; Sodium | 2000 |
Contribution of endogenous endothelin in the enhanced coronary constriction in DOCA-salt hypertensive rats.
Topics: Angiotensin II; Animals; Coronary Circulation; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Heart; Hypertension; In Vitro Techniques; Male; Nephrectomy; Oligopeptides; Propionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Signal Transduction; Sodium Chloride; Vasoconstriction; Vasoconstrictor Agents; Vasopressins | 2003 |
Vasoconstrictive effect of angiotensin IV in isolated rat basilar artery independent of AT1 and AT2 receptors.
Topics: Angiotensin II; Animals; Basilar Artery; Drug Interactions; Endothelin-1; Endothelium, Vascular; Gene Expression; In Vitro Techniques; Male; Oligopeptides; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasoconstriction; Vasoconstrictor Agents | 2006 |